Blind Assessment of the Concordance Between the Administered Treatment and the Recommendations of a Medical Algorithm Decision Support Software in Systolic Heart Failure (PREMEDIC)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02900547|
Recruitment Status : Unknown
Verified June 2016 by Central Hospital, Nancy, France.
Recruitment status was: Recruiting
First Posted : September 14, 2016
Last Update Posted : September 14, 2016
The PREMEDIC is a prospective, observational study. Patients hospitalized for Systolic Heart Failure will be enrolled and health data will be collected at hospital admission and during hospital stay. No data will be collected before detailed information is given to the patient and a non-opposition is obtained.
The aim of this observational and prospective study is to evaluate the concordance actual patient management during the in hospital treatment of heart failure and the therapeutic proposals from a medical algorithmic decision support software.
|Condition or disease||Intervention/treatment|
|Hearth Failure, Systolic||Other: Patients with systolic heart failure|
The aim of this observational and prospective study is to evaluate retrospectively the concordance between the actual systolic heart failure patient management during the inhospital treatment of heart failure (as recorded from the usual healthcare data collected) and the therapeutic proposals from a medical algorithmic decision support software.
To study the evolution of biological, hepatic and cardiopulmonary ultrasound usual markers in hospitalization, in connection with the duration of hospitalization and drug administered.
|Study Type :||Observational|
|Estimated Enrollment :||300 participants|
|Official Title:||Blind Assessment of the Concordance Between the Administered Treatment and the Recommendations of a Medical Algorithm Decision Support Software in Systolic Heart Failure|
|Study Start Date :||July 2015|
|Estimated Primary Completion Date :||June 2018|
|Estimated Study Completion Date :||June 2018|
- Retrospective evaluation of the concordance between the drug therapy actually used and the therapeutic algorithm's proposals [ Time Frame: an average of 7 days ]
- Duration of hospitalization (number of days) [ Time Frame: an average of 7 days ]
- Weight evolution (Kilograms) [ Time Frame: an average of 7 days ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02900547
|Contact: Patrick ROSSIGNOL, Professor||0033383157322 ext +firstname.lastname@example.org|
|Contact: Nicolas GIRERD||0033383157322 ext +email@example.com|
|CHRU de Nancy||Recruiting|
|Contact: Patrick Rossignol, Prof|
|Principal Investigator: Patrick Rossignol, Prof|
|Sub-Investigator: Nicolas GIRERD|